{
    "Trade/Device Name(s)": [
        "OneTouch Verio Blood Glucose Monitoring System",
        "OneTouch Verio Sync Blood Glucose Meter",
        "OneTouch Verio Test Strips",
        "OneTouch Verio Level 3 Control Solution",
        "OneTouch Verio Level 4 Control Solution"
    ],
    "Submitter Information": "LifeScan Europe, a Div. of Cilag GmbH International",
    "510(k) Number": "K131363",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110637"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "July 25, 2013",
    "Summary Letter Received Date": "July 29, 2013",
    "Submission Date": "May 9, 2013",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "OneTouch Verio Sync Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "Electrochemical reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for OneTouch Verio Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood from the fingertip",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood drawn from the fingertip by a single patient for self-testing at home to monitor diabetes control; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}